Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres
- Written by PR Newswire
![]() |
Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories.
WOBURN, Mass., Sept. 8, 2025 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of minimally invasive interventional oncology solutions, today announced that it has received an expanded CE Mark approval for SIR-Spheres® Y-90 re...
Read more: Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres